Effect of the Administration of L-Carnitine on Body Weight in Women in Crossfit Training

• Status: Unknown status
• Trial end date: 2019-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

The L-carnitine has demonstrated effects in the treatment of obesity mainly promoting the fat degradation during exercise.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Guadalajara

Criteria

Inclusion Criteria:

• Volunteers who practice crossfit regularly (who have 3 months prior to the beginning of the study practicing crossfit).

• Volunteers with a body mass index equal to or greater than 25 Kg/m2.

• Volunteers who do not have allergies to L-Carnitine or any of its components.

• Informed consent signed

• Women with a recommendation of nutrition two weeks prior to the start of the study.

• Body weight stable the last 3 months.

Exclusion Criteria:

• Volunteers with pathologies such as diabetes, hypertension, metabolic syndrome and allergies.

• Women with confirmed or suspected pregnancy.

• Women under lactation and/or puerperium.

• Hypersensibilility to L-Carnitine or Sucralose.

• Kown of renal, hepatic or thyroid deseased.

• Current or previous treatment diet (3 months before inclusion to the study).

• Current pharmacological treatment for loose body weight or 3 months before inclusion to the study.